# B-PaLMZ for TB Meningitis

> **NCT07227779** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Minnesota** · enrollment: 240 (estimated)

## Conditions studied

- Tuberculous Meningitis

## Interventions

- **DRUG:** BPaLMZ Regimen

## Key facts

- **NCT ID:** NCT07227779
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2030-08-31
- **Final completion:** 2030-08-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07227779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07227779, "B-PaLMZ for TB Meningitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07227779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*